A Clinical Analysis of Fast Conversion of Paroxysmal Supraventricular Tachycardia by Vera Pamil
HUANG Hai-yan
LI Yu-lan
HONG Yun-yu
Abstract：Objective:To observe the treatment effect and adverse reactions of fast conversion of paroxysmal supraventricular tachycardia by Verapamil. Method:Clinical data of patients with paroxysmal supraventricular tachycardia treated with at least once intravenous injection of Verapamil in our hospital from January 2010 to June 2013(n=103) were analyzed.The first loading dose was 5 mg Verapamil in 20 ml of 5%glucose or physiological saline solution,and it was intravenously injected within 5 to 10 min,which was suspended immediately if supraventricular tachycardia was switched to sinus rhythm during the injection,and a repeated injection was did after 20 min if the first dose was ineffective.Result:There were 96 cases in 103 cases successfully restored their sinus rhythms,and the success rate was 93.2%,and 8 cases(7.8%) showed adverse reactions.Conclusion:Verapamil is effective to treat paroxysmal supraventricular tachycardia with a high cardioversion rate and fewer adverse reaction.Therefore,it should be the first-line drug in the treatment of paroxysmal supraventricular tachycardia in the emergency room,and a correct use method may further improve its effect.
Keywords：VerapamilFast conversionParoxysmal supraventricular tachycardia
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 25-25,26 )